Literature DB >> 10642603

Characterization of high affinity monoclonal antibodies specific for chlamydial lipopolysaccharide.

S Müller-Loennies1, C R MacKenzie, S I Patenaude, S V Evans, P Kosma, H Brade, L Brade, S Narang.   

Abstract

Pathogens belonging to the genus Chlamydia contain lipopolysaccharide with a 3-deoxy-D- manno- oct-2-ulosonic acid (Kdo) trisaccharide of the sequence alpha-Kdo-(2-->8)-alpha-Kdo-(2-->4)-alpha-Kdo. This lipopolysaccharide is recognized in a genus-specific pattern by murine monoclonal antibodies (mAbs), S25-23 and S25-2 (both IgG1kappa), which bind as the minimal structures the trisaccharide and the terminal Kdo-disaccharide, respectively. The variable domains of these mAbs were reverse transcribed from mRNA which was isolated from hybridomas and cloned as single-chain variable fragments (scFvs) in E.coli TG1. The kinetics of binding of whole antibodies, Fab fragments and scFvs to natural and synthetically modified ligands were determined by surface plasmon resonance (SPR) using synthetic neoglycoconjugates. As examples of an antibody-carbohydrate interaction involving anionic carboxyl groups on the ligand, we report that the affinities of these antibodies are higher than usually observed in carbo-hydrate-protein interactions (K(D)of 10(-3)to 10(-5)M). SPR analy-ses of monovalent Fab and scFv binding to the natural trisaccharide epitope gave dissociation constants of 770 nM for S25-2 and 350 nM for S25-23, as determined by global fitting (simultaneous fitting of several measurements at different antibody concentrations) of sensorgram data to a one-to-one interaction model. Local fitting (separate fitting of individual sensorgram data at different antibody concentrations) and Scatchard analysis of the data gave kinetic and affinity constants that were in good agreement with those obtained by global fitting. The SPR data also showed that while S25-2 bound well to several Kdo disaccharides and carboxyl-reduced Kdo ligands, S25-23 did not. Identification of amino acids in the complementarity determining regions revealed the presence of a large number of positively charged amino acids which were located towards the center of the combining site, thus suggesting a different recognition mechanism than that observed for neutral ligands. The latter mainly involves aromatic amino acids for hydrophobic stacking inter-actions and hydrogen bonds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642603     DOI: 10.1093/glycob/10.2.121

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  13 in total

1.  Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Radka Saldova; Mohankumar Muniyappa; Lore Brade; Pauline M Rudd; David J Harvey; Paul Kosma; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2014-03-28       Impact factor: 5.157

2.  Analysis of cross-reactive and specific anti-carbohydrate antibodies against lipopolysaccharide from Chlamydophila psittaci.

Authors:  Sandra Gerstenbruch; Cory L Brooks; Paul Kosma; Lore Brade; C Roger Mackenzie; Stephen V Evans; Helmut Brade; Sven Müller-Loennies
Journal:  Glycobiology       Date:  2009-12-18       Impact factor: 4.313

3.  Structural characterization and MHCII-dependent immunological properties of the zwitterionic O-chain antigen of Morganella morganii.

Authors:  N Martin Young; Lori S C Kreisman; Jacek Stupak; Leann L MacLean; Brian A Cobb; James C Richards
Journal:  Glycobiology       Date:  2011-02-14       Impact factor: 4.313

4.  Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.

Authors:  Amy Pham; Emma L Ledger; Carrie F Coggon; Ian R Henderson; David W Reid; Scott C Bell; Daniel J Smith; Timothy J Wells
Journal:  Infect Immun       Date:  2021-08-30       Impact factor: 3.441

5.  Antibodies raised against chlamydial lipopolysaccharide antigens reveal convergence in germline gene usage and differential epitope recognition.

Authors:  Cory L Brooks; Sven Müller-Loennies; Svetlana N Borisova; Lore Brade; Paul Kosma; Tomoko Hirama; C Roger Mackenzie; Helmut Brade; Stephen V Evans
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

6.  Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258.

Authors:  Valéria Szijártó; Luis M Guachalla; Katharina Hartl; Cecília Varga; Adriana Badarau; Irina Mirkina; Zehra C Visram; Lukas Stulik; Christine A Power; Eszter Nagy; Gábor Nagy
Journal:  Virulence       Date:  2017-01-19       Impact factor: 5.882

7.  2D transition metal dichalcogenides with glucan multivalency for antibody-free pathogen recognition.

Authors:  Tae Woog Kang; Juhee Han; Sin Lee; In-Jun Hwang; Su-Ji Jeon; Jong-Min Ju; Man-Jin Kim; Jin-Kyoung Yang; Byoengsun Jun; Chi Ho Lee; Sang Uck Lee; Jong-Ho Kim
Journal:  Nat Commun       Date:  2018-06-29       Impact factor: 14.919

8.  Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus.

Authors:  Kyeonghye Guk; Hyeran Kim; Miyeon Lee; Yoon-Aa Choi; Seul Gee Hwang; Gaon Han; Hye-Nan Kim; Hongki Kim; Hwangseo Park; Dongeun Yong; Taejoon Kang; Eun-Kyung Lim; Juyeon Jung
Journal:  Nat Commun       Date:  2020-07-09       Impact factor: 14.919

9.  High-throughput sorting of the highest producing cell via a transiently protein-anchored system.

Authors:  Kuo-Hsiang Chuang; Yuan-Chin Hsieh; I-Shiuan Chiang; Chih-Hung Chuang; Chien-Han Kao; Ta-Chun Cheng; Yeng-Tseng Wang; Wen-Wei Lin; Bing-Mae Chen; Steve R Roffler; Ming-Yii Huang; Tian-Lu Cheng
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

10.  Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans.

Authors:  Felix Broecker; Jonas Hanske; Christopher E Martin; Ju Yuel Baek; Annette Wahlbrink; Felix Wojcik; Laura Hartmann; Christoph Rademacher; Chakkumkal Anish; Peter H Seeberger
Journal:  Nat Commun       Date:  2016-04-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.